- Alefacept is a well tolerated drug with a very impressive safety profile.
- It has a convenient and flexible method of administration (IM)
- Patient self-administration is possible (nurse administration available)
- Patient expectations must be set appropriately:
- The onset of response occurs on average at 8 weeks; maximal response, for one course, occurring at 20 weeks (8 weeks after the last dose)
- Completing 2 courses of therapy has shown remittive effects lasting >12 months
- Clinical experience combining Alefacept with UV therapy, oral retinoids, methotrexate and cyclosporin has been well tolerated
Amevive Care Program
The program offers:
- Help in determining and acquiring reimbursement
- A personal nurse coordinator to help guide patient expectations
- In-office, self-administration or Amevive nurse administration available
- A toll-free hotline available 7 days a week (1-877-AMEVIVE or 1-877-263-8483) staffed by specially trained nurses
- An Amevive patient starter kit
- Home delivery if needed
